CMPD — CompuMed Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
- $4.44m
- $4.78m
- $1.65m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 40.39 | ||
| Price to Tang. Book | 1,481.11 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.46 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -45.95% | ||
| Return on Equity | -196.21% | ||
| Operating Margin | -10.36% | ||
Financial Summary
| Year End 30th Sep | Unit | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 2.15 | 2.05 | 1.76 | 1.68 | 1.65 | n/a | n/a | -5.71% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CompuMed, Inc. provides diagnostic telemedicine solutions to organizations seeking clinical care. The Company's solutions provide real-time access to United States Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities. Its solutions primarily support the diagnosis and treatment of several high incidence diseases, including cardiovascular disease. The Company provides subspecialty diagnostic reading services focused on telecardiology, teleradiology and telepathology solutions. It has established a network for remote electronic processing of electrocardiograms (ECGs), echocardiograms (Echos), ultrasound studies, X-rays and other specialty radiology. Its platform, custom tools, and infrastructure allow its customers to upload medical imaging data collected at the patient's point of care into its cloud servers. It serves various markets, including organ donor and transplant, correctional healthcare, hospitals, and imagine centers.
Directors
- Mark Stolper CHM (49)
- Lee Keddie CCE
- David Pointer CCE (51)
- Phuong Dang CFO (54)
- Charles Gillman DRC (50)
- Loren Den Herder DRC
- Mark Crockett IND (45)
- Last Annual
- September 30th, 2012
- Last Interim
- June 30th, 2013
- Incorporated
- July 21st, 1986
- Public Since
- May 28th, 1987
- No. of Employees
- 8
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 1,316,539
- Address
- 5777 W Century Blvd Ste 360, LOS ANGELES, 90045
- Web
- https://compumedinc.com/
- Phone
- +1 3102585000
- Auditors
- Rose, Snyder & Jacobs
Upcoming Events for CMPD
Q3 2025 CompuMed Inc Earnings Release
Similar to CMPD
4Cable TV International
Pink Sheets on Nasdaq
Abattis Bioceuticals
Pink Sheets on Nasdaq
Accelera Innovations
Pink Sheets on Nasdaq
Quantum Medical Transport
Pink Sheets on Nasdaq
Aesthetic Medical International Holdings
Pink Sheets on Nasdaq
FAQ
What is the CompuMed share price?
As of Today at 20:02 UTC, shares in CompuMed are trading at $3.38. This share price information is delayed by 15 minutes.
How has the CompuMed share price performed this year?
Shares in CompuMed last closed at $3.38 and the price had moved by +98.53% over the past 365 days. In terms of relative price strength the CompuMed share price has outperformed the S&P500 Index by +85.48% over the past year.
What are the analyst and broker recommendations for CompuMed?
There is no consensus recommendation for this security.
Find out moreWhat is the CompuMed dividend yield?
CompuMed does not currently pay a dividend.
Does CompuMed pay a dividend?
CompuMed does not currently pay a dividend.
When does CompuMed next pay dividends?
CompuMed does not currently pay a dividend.
How do I buy CompuMed shares?
To buy shares in CompuMed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of CompuMed?
As of the previous close price of $3.38, shares in CompuMed had a market capitalisation of $4.44m.
Where are CompuMed shares listed?
Here are the trading details for CompuMed:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CMPD
What kind of share is CompuMed?
Based on an overall assessment of its quality, value and momentum CompuMed is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a CompuMed share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the CompuMed share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like CompuMed. Over the past six months, its share price has outperformed the S&P500 Index by +9.18%.
As of the last closing price of $3.38, shares in CompuMed were trading +22.85% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the CompuMed PE Ratio?
The CompuMed PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $3.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of CompuMed?
CompuMed's management team is headed by:
- Mark Stolper - CHM
- Lee Keddie - CCE
- David Pointer - CCE
- Phuong Dang - CFO
- Charles Gillman - DRC
- Loren Den Herder - DRC
- Mark Crockett - IND